The Effectiveness of GLP-1R Agonist Liraglutide within ERAS Protocols

Following the publication of ¿GLP-1 Receptor Agonist Liraglutide is an Effective Therapeutic Option for Perioperative Glycemic Control in Type 2 Diabetes within Enhanced Recovery After Surgery (ERAS) Protocols¿ in 2018. I received many questions from several countries concerning the details of the practical methods of this protocol. Based on this manuscript, I will describe theories and practices regarding the application of this protocol in various clinical settings. I strongly believe that this book will help in the treatment of patients undergoing operations and aid doctors and other medical staff due in no small part to the fact that this book has been written based on more than 5 years real-world experience.